LynxDx is working to commercialize a prostate cancer urine diagnostic assay that is able to confidently prevent many unnecessary prostate biopsies. The test, called the MyProstateScore (MPS) is performed in a regulatory-compliant commercial laborator
Last seen: June 17th at 6:49pm — Visit site